JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Appel, N. M.
Right arrow Articles by Van Loon, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Appel, N. M.
Right arrow Articles by Van Loon, G. R.

beta-Endorphin-induced stimulation of central sympathetic outflow: inhibitory modulation by central noradrenergic neurons

NM Appel and GR Van Loon

Endorphins, a class of endogenous opioid peptides, produce a diversity of physiological effects attributable to their actions in the central nervous system. We have reported previously the effect of intracisternal (i.c.) administration of synthetic human beta-endorphin to increase plasma catecholamine concentrations, presumably by acting at opioid receptors in the brain to stimulate the central sympathetic outflow to adrenal medulla and peripheral sympathetic nerve terminals. This beta-endorphin-induced increase in plasma catecholamine concentration is dose-dependent, inhibited by naloxone and blocked by bilateral adrenal gland denervation or ganglionic blockade with chlorisondamine. We also provided evidence supporting involvement of central cholinergic, somatostatin and angiotensin II neuronal systems in modulating this beta-endorphin-induced effect. In this study we examined the possibility of central noradrenergic regulation of beta- endorphin-induced catecholamine secretion. Simultaneous i.c. administration of norepinephrine with beta-endorphin blunted the plasma epinephrine response to i.c. beta-endorphin in conscious, unrestrained rats bearing chronic i.a. cannulas. On the other hand, depletion of brain norepinephrine by prior i.c. 6-hydroxydopamine (6-OHDA) treatment potentiated the plasma epinephrine response to i.c. beta-endorphin. In addition, rats pretreated with 6-OHDA appeared supersensitive to the blunting effect of i.c. norepinephrine on beta-endorphin-induced catecholamine secretion. Specifically, i.c. norepinephrine at a dose insufficient to reduce beta-endorphin-induced catecholamine secretion in vehicle-treated rats prevented beta-endorphin-induced epinephrine and norepinephrine secretion in rats whose brains had been depleted of norepinephrine by prior 6-OHDA treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 237, Issue 3, pp. 695-701, 06/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics.